Full MIST2 dosing of intrapleural enzyme therapy varies widely across hospitals and is associated with a lower risk for ...

Shivrat Chhabra is CEO of Dosis, a company that offers an artificial intelligence-powered personalized dosing platform used by dialysis providers to manage chronic drug regimens. Dosis developed the ...

Using GLP-1s or considering it? New global research reveals social and psychological consequences for everyday lives.

In a subgroup analysis of patients with polypoidal choroidal vasculopathy, aflibercept 8 mg achieved similar vision gains to ...

Neck Dissections Based on Sentinel Lymph Node Navigation Versus Elective Neck Dissections in Early Oral Cancers: A Randomized, Multicenter, and Noninferiority Trial Sixty studies, primarily ...

Medication adherence is important in chronic disease management. This systematic review demonstrates that dosing frequency has important effects on medication adherence. Four electronic databases were ...

Regeneron has won US Food and Drug Administration (FDA) approval for Lynozyfic (linvoseltamab-gcpt), marking the entry of another BCMAxCD3 bispecific drug in the multiple myeloma (MM) treatment space.